The effects of time and temperature on the in vitro stability of emicizumab in blood samples: Implications for laboratory and clinical practices

Haemophilia. 2024 Mar;30(2):554-557. doi: 10.1111/hae.14923. Epub 2023 Dec 25.

Authors

Nûn K Bentounes¹, Dominique Lasne^{1

2}, Capucine Habay¹, Cécile Bally³, Laurent Frenzel³, Annie Harroche³, Delphine Borgel^{1

2}, Claire Auditeau^{1

2}

Affiliations

¹ Laboratoire d'Hématologie Biologique, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
² HITh, UMR_S 1176, INSERM, Univ. Paris-Saclay, Le Kremlin-Bicêtre, France.
³ Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, Paris, France.

PMID: 38146237
DOI: 10.1111/hae.14923

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Bispecific* / pharmacology
Antibodies, Monoclonal, Humanized / pharmacology
Factor VIII
Hemophilia A*
Humans
Temperature

Substances

emicizumab
Antibodies, Bispecific
Antibodies, Monoclonal, Humanized
Factor VIII